Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine.

Autor: Barateiro LGRP; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Oliveira Cavagna R; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Dos Reis MB; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Paula FE; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Teixeira GR; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Moreno DA; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Bonatelli M; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Santana I; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Saggioro FP; Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil., Neder L; Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil., Stavale JN; Federal University of São Paulo, São Paulo, Brazil., Malheiros SMF; Federal University of São Paulo, São Paulo, Brazil., Garcia-Rivello H; Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Christiansen S; Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Nunes S; São João Hospital, Porto, Portugal., da Costa MJG; São João Hospital, Porto, Portugal., Pinheiro J; São João Hospital, Porto, Portugal., Júnior CA; Pediatric Department, Barretos Cancer Hospital, Barretos, Brazil., Mançano BM; Pediatric Department, Barretos Cancer Hospital, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal.

Publikováno v: Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2024 May 12. Date of Electronic Publication: 2024 May 12.

Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors.

Autor: Steinbügl M; University Medical Center Augsburg, Paediatric and Adolescent Medicine, Swabian Children's Cancer Center, Augsburg, Germany., Nemes K; University Medical Center Augsburg, Paediatric and Adolescent Medicine, Swabian Children's Cancer Center, Augsburg, Germany., Johann P; University Medical Center Augsburg, Paediatric and Adolescent Medicine, Swabian Children's Cancer Center, Augsburg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Kröncke T; Department of Diagnostic and Interventional Radiology, University Medical Center, Augsburg, Germany., Tüchert S; Department of Diagnostic and Interventional Radiology, University Medical Center, Augsburg, Germany., da Costa MJG; Pediatric Hematology and Oncology Division, University Hospital S. João Alameda Hernani Monteiro, Porto, Portugal., Ebinger M; Department of General Pediatrics, Hematology and Oncology, Children's University Hospital, Tübingen, Germany., Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sehested A; Department of Paediatrics and Adolescent Medicine Rigshospitalet, Copenhagen, Denmark., Hauser P; Department of Pediatric Oncology, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary., Reinhard H; Department of Pediatrics, Asklepios Kinderklinik Sankt Augustin, Sankt Augustin, Germany., Sumerauer D; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic., Hettmer S; Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Jakob M; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital of Regensburg, Regensburg, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Siebert R; Institute of Human Genetics, University of Ulm and Ulm University Hospital, Ulm, Germany., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Gerss J; Institute of Biostatistics and Clinical Research, University of Münster, Muenster, Germany., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Frühwald MC; University Medical Center Augsburg, Paediatric and Adolescent Medicine, Swabian Children's Cancer Center, Augsburg, Germany.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Dec; Vol. 68 (12), pp. e29267. Date of Electronic Publication: 2021 Aug 04.